The phase 3 SURMOUNT programme assessed the safety and efficacy of tirzepatide as obesity treatment and the medication has now been approved (November 2023) for chronic weight management by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) [46, 47]
That does not mean GLP-1 medications are a problem
Glpcare.org, by contrast, integrates biometric monitoring with medical oversightideal for individuals desiring enhanced visibility into their metabolic health trends during therapy
However, they can cause stomach discomfort, so steer clear of them
After the backbone is synthesized, the molecule is cleaved chemically, then purified
10.3389/fimmu.2021.688215 Summary Keywords GLP-1, pan-cancer, prognosis, immune infiltration, immunotherapy Citation Zhu C, Lai Y, Liu C, Teng L, Zhu Y, Lin X, Fu X, Lai Q, Liu S, Zhou X and Fang Y (2024) Comprehensively prognostic and immunological analyses of GLP-1 signaling-related genes in pan-cancer and validation in colorectal cancer
